Chemoinformaics analysis of gallic acid-methylester
| Molecular Weight | 272.253 | nRot | 3 |
| Heavy Atom Molecular Weight | 256.125 | nRig | 9 |
| Exact Molecular Weight | 272.09 | nRing | 1 |
| Solubility: LogS | -1.087 | nHRing | 0 |
| Solubility: LogP | -0.476 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 35 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 19 | No. of Aromatic Carbocycles | 0 |
| nHetero | 7 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 12 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 7 | No. of Arom Bond | 0 |
| nHA | 7 | APOL | 36.3227 |
| nHD | 3 | BPOL | 20.3913 |
| QED | 0.534 |
| Synth | 4.318 |
| Natural Product Likeliness | 1.181 |
| NR-PPAR-gamma | 0.001 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.185 |
| HIA | 0.226 |
| CACO-2 | -5.076 |
| MDCK | 0.0000939 |
| BBB | 0.402 |
| PPB | 0.246865 |
| VDSS | 0.43 |
| FU | 0.611482 |
| CYP1A2-inh | 0.003 |
| CYP1A2-sub | 0.978 |
| CYP2c19-inh | 0.017 |
| CYP2c19-sub | 0.49 |
| CYP2c9-inh | 0.005 |
| CYP2c9-sub | 0.294 |
| CYP2d6-inh | 0.002 |
| CYP2d6-sub | 0.154 |
| CYP3a4-inh | 0.007 |
| CYP3a4-sub | 0.155 |
| CL | 2.091 |
| T12 | 0.667 |
| hERG | 0.01 |
| Ames | 0.107 |
| ROA | 0.059 |
| SkinSen | 0.136 |
| Carcinogencity | 0.038 |
| EI | 0.044 |
| Respiratory | 0.862 |
| NR-Aromatase | 0.495 |
| Antiviral | Yes |
| Prediction | 0.801185 |